A randomized, phase IIa exploratory trial to assess the safety and preliminary efficacy of LEO 43204 in patients with actinic keratosis

Overview of attention for article published in British Journal of Dermatology, January 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

So far, Dimensions has found 12 publications that cite this research output.

Article in EJC Skin Cancer (January 2023)

Book chapter (August 2021)

Article in Expert Opinion on Drug Safety (April 2021)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.